Sveriges mest populära poddar
Eye On A.I.
Teknologi

Episode 29 - Daphne Koller

43 min•11 december 2019

Daphne Koller, formerly at Stanford University and cofounder of the online education company, Coursera, talks this week about using machine-learning to develop new drugs. Her approach is to use machine learning to accuratley identify cellular or genetic targets for treatment. The field is just getting started but promises to speed the development of new and better therapies to treat disease.

Fler avsnitt av Eye On A.I.

Visa alla avsnitt av Eye On A.I.
AI Is Reading 15 Million X-Rays a Year With No Human in the Loop | Prashant Warier, Qure.ai
•42 min
Only 12% of Companies Generate Value From AI. Here's What They're Doing | Sanjeev Vohra, Genpact
•59 min
India Is Becoming an Architect of the Global AI Order | Ivana Bartoletti of Wipro
•56 min
The New BRAIN Of the Enterprise | Ryan Gavin
•53 min
AI Is Already Resolving 90% of Customer Service Tickets - and It's Getting Smarter | Shashi Upadhyay, Zendesk
•57 min
Every Enterprise Is About to Have a 100,000 Agent Problem | Oren Michaels of Barndoor AI
•1 tim
More Customers Chose the AI Agent Than Anyone Expected | Tom Chen, Aircall
•57 min
Why the Future of AI Isn't Just Bigger Models. It's Models That Evolve | Risto Miikkulainen of Cognizant
•1 tim 4 min
How AI Is Reinventing Elder Care | Chia-Lin Simmons of LogicMark
•53 min
The App of the Future Is Voice — Not a Screen. Mitel's CTO Luiz Domingos Explains Why.
•55 min

Eye On A.I. med Craig S. Smith finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.